This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview

Christian Blank group

Blank, Christiaan

Christian Blank

Group Leader

Personal details


Our research aim is to identify optimal combinations of targeted and immunotherapy to improve the efficacy of these therapies. Our focus is on melanoma and renal cell carcinoma, as these cancers are thought the most immunogenic cancers, but recent data indicate that immunotherapy can work also in cancers of the lung, breast, ovary, bowel and head&neck. In detail our research focus is on the topics:

  1. Improving animal models of melanoma to simulate immunotherapy pre-clinically
  2. Identify optimal combinations of multiple targeted therapies and immunotherapies

Identify patients that most likely benefit from such approaches and transfer such approaches to the clinic

Share this page